A
Agilent Technologies, Inc. NYSE$114.52
Mkt Cap $32.5B
52w Low $104.10
18.6% of range
52w High $160.27
50d MA $116.81
200d MA $129.57
P/E (TTM)
24.9x
EV/EBITDA
23.4x
P/B
4.8x
Debt/Equity
0.5x
ROE
18.7%
P/FCF
36.0x
RSI (14)
—
ATR (14)
—
Beta
1.30
50d MA
$116.81
200d MA
$129.57
Avg Volume
2.2M
About
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled pl…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 1.37 | 1.36 | -0.7% | 124.72 | -2.3% | -3.0% | -2.7% | -5.3% | -4.6% | -3.4% | -11.6% | — |
| Nov 24, 2025 | AMC | 1.58 | 1.59 | +0.4% | 153.60 | -1.8% | +2.3% | +0.5% | -0.1% | -2.3% | -3.1% | -9.9% | — |
| Aug 27, 2025 | AMC | 1.37 | 1.37 | +0.0% | 118.69 | +0.1% | +5.3% | +5.9% | +5.5% | +5.5% | +8.2% | +4.0% | — |
| May 28, 2025 | AMC | 1.26 | 1.31 | +4.0% | 110.88 | +5.5% | +2.2% | +0.9% | +0.2% | +1.7% | +3.7% | +7.5% | — |
| Feb 26, 2025 | AMC | 1.28 | 1.31 | +2.3% | 134.47 | -4.2% | -5.5% | -4.9% | -6.1% | -8.5% | -5.9% | -13.2% | — |
| Nov 25, 2024 | AMC | 1.41 | 1.46 | +3.5% | 134.49 | -5.6% | -0.1% | +2.7% | +2.6% | +3.8% | +3.6% | +1.0% | — |
| Aug 21, 2024 | AMC | 1.26 | 1.32 | +4.8% | 139.99 | +3.9% | +0.2% | +0.6% | +0.4% | +0.8% | +0.8% | +0.1% | — |
| May 29, 2024 | AMC | 1.19 | 1.22 | +2.5% | 145.48 | -13.9% | -9.7% | -10.4% | -9.7% | -10.1% | -8.2% | -10.9% | — |
| Feb 27, 2024 | AMC | 1.22 | 1.29 | +5.7% | 132.55 | +5.5% | +3.4% | +3.6% | +4.9% | +7.8% | +8.9% | +9.8% | — |
| Nov 20, 2023 | AMC | 1.34 | 1.38 | +3.0% | 113.98 | +6.6% | +8.7% | +8.8% | +11.1% | +9.7% | +9.4% | +21.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | KeyBanc Capital Markets | Maintains | Sector Weight → Sector Weight | — | $115.62 | $116.23 | +0.5% | -0.6% | -3.7% | -0.1% | -1.0% | — |
| Apr 14 | Barclays | Maintains | Overweight → Overweight | — | $117.50 | $118.04 | +0.5% | +2.5% | +1.9% | +0.6% | +3.7% | +2.9% |
| Apr 13 | TD Cowen | Maintains | Buy → Buy | — | $115.06 | $114.94 | -0.1% | +2.1% | +4.6% | +4.1% | +2.8% | +5.9% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $115.48 | $115.14 | -0.3% | -0.6% | -1.4% | +1.2% | -0.1% | -0.4% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $118.17 | $116.64 | -1.3% | +0.7% | +2.0% | -0.1% | -2.6% | -1.3% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $124.72 | $121.89 | -2.3% | -3.0% | -2.7% | -5.3% | -4.6% | -3.4% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $124.72 | $121.89 | -2.3% | -3.0% | -2.7% | -5.3% | -4.6% | -3.4% |
| Feb 26 | TD Cowen | Maintains | Buy → Buy | — | $124.72 | $121.89 | -2.3% | -3.0% | -2.7% | -5.3% | -4.6% | -3.4% |
| Feb 26 | Barclays | Maintains | Overweight → Overweight | — | $124.72 | $121.89 | -2.3% | -3.0% | -2.7% | -5.3% | -4.6% | -3.4% |
| Jan 5 | Evercore ISI | Upgrade | In Line → Outperform | — | $137.95 | $137.67 | -0.2% | +3.6% | +7.0% | +7.1% | +5.7% | +7.7% |
Recent Filings
8-K · 5.02
!!! Very High
Agilent Technologies, Inc. -- 8-K 5.02: Executive Change
Agilent Technologies (A) lost Senior Vice President Bret DiMarco to resignation, potentially signaling leadership transitions that investors should monitor for strategic impact.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
DiMarco's departure signals potential leadership instability and removes equity incentives for 2026, likely indicating a planned exit that could pressure stock performance if investors lose confidence in management continuity.
Apr 6
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This Regulation FD disclosure likely contains forward-looking statements about company plans or expectations, signaling management's optimistic outlook but with limited legal liability if projections fail to materialize.
Apr 3
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An executive departure at Agilent Technologies could signal leadership transitions or strategic changes, potentially affecting operational continuity and investor confidence in company direction.
Apr 3
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A leadership transition to a new CFO effective March 30, 2026 signals potential strategic shifts in financial management and capital allocation that investors should monitor for signs of operational changes or guidance updates.
Mar 27
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
Agilent's strong 88% shareholder attendance at its annual meeting signals robust investor engagement and validates management's governance practices, reducing proxy contest risks.
Mar 20
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An executive's departure with a general release suggests potential internal turmoil or strategic disagreement, which could create uncertainty about company direction and leadership stability that investors should monitor closely.
Mar 17
8-K · 5.02
!!! Very High
Agilent Technologies Inc. -- 8-K 5.02: Executive Change
Agilent Technologies' Vice President and Principal Accounting Officer Rodney Gonsalves will retire in January 2027, requiring investors to monitor leadership transition execution and accounting function continuity.
Mar 6
8-K
Agilent Technologies Inc. -- 8-K Filing
Agilent Technologies disclosed its use of non-GAAP financial metrics in investor communications, emphasizing that these supplementary measures complement but do not replace standard GAAP reporting requirements.
Feb 25
Data updated apr 24, 2026 10:01am
· Source: massive.com